To amend the National Organ Transplant Act to prevent the sale of bone marrow and umbilical cord blood, and for other purposes.

Bill: 113-hr-589
Sponsor: full_name: Rep. Young, C. W. Bill [R-FL-13]
Introduced: 2013-02-06
Policy area: Health
Subjects: Blood and blood diseases

Medical ethics

Organ and tissue donation and transplantation

Retail and wholesale trades
Latest action: action_date: 2013-02-08
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2013-02-06
action_desc: Introduced in House
text: <p>Amends the National Organ Transplant Act to prohibit acquiring, receiving, or otherwise transferring a cord blood unit (the neonatal blood collected from the placenta and umbilical cord of a single newborn baby) for valuable consideration for use in human transplantation if the transfer affects interstate commerce.</p>

tv_txt: I 113th CONGRESS 1st Session H. R. 589 IN THE HOUSE OF REPRESENTATIVES February 6, 2013 Mr. Young of Florida (for himself and Ms. Matsui ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the National Organ Transplant Act to prevent the sale of bone marrow and umbilical cord blood, and for other purposes.

1. Amendment to the National Organ Transplant Act to prevent the sale of bone marrow and umbilical cord blood Paragraph 1 of section 301(c) of the National Organ Transplant Act ( 42 U.S.C. 274e(c) ) is amended— (1) by inserting (as defined in section 379A–1 of the Public Health Service Act ( 42 U.S.C. 274l–1 )) after bone marrow ; and (2) by inserting , a cord blood unit (as defined in section 2(g) of the Stem Cell Therapeutic and Research Act of 2005 ( 42 U.S.C. 274k note)), after skin or any subpart therof .